91 related articles for article (PubMed ID: 22395769)
1. Hepatitis C and substance use: new treatments and novel approaches.
North CS; Hong BA; Kerr T
Curr Opin Psychiatry; 2012 May; 25(3):206-12. PubMed ID: 22395769
[TBL] [Abstract][Full Text] [Related]
2. [New treatments for hepatitis C, which targets, what timeline?].
Goossens N; Negro F
Rev Med Suisse; 2011 Sep; 7(307):1683-8. PubMed ID: 21987876
[TBL] [Abstract][Full Text] [Related]
3. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.
Butt AA; Kanwal F
Clin Infect Dis; 2012 Jan; 54(1):96-104. PubMed ID: 22156853
[TBL] [Abstract][Full Text] [Related]
4. New developments in HCV therapy.
Kronenberger B; Zeuzem S
J Viral Hepat; 2012 Jan; 19 Suppl 1():48-51. PubMed ID: 22233414
[TBL] [Abstract][Full Text] [Related]
5. Future of hepatitis C therapy: development of direct-acting antivirals.
Dore GJ; Matthews GV; Rockstroh J
Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228
[TBL] [Abstract][Full Text] [Related]
6. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C.
Jacobson IM; Pawlotsky JM; Afdhal NH; Dusheiko GM; Forns X; Jensen DM; Poordad F; Schulz J
J Viral Hepat; 2012 May; 19 Suppl 2():1-26. PubMed ID: 22404758
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus therapy update 2013.
Casey LC; Lee WM
Curr Opin Gastroenterol; 2013 May; 29(3):243-9. PubMed ID: 23563981
[TBL] [Abstract][Full Text] [Related]
8. New pharmacotherapy for hepatitis C.
Assis DN; Lim JK
Clin Pharmacol Ther; 2012 Sep; 92(3):294-305. PubMed ID: 22850602
[TBL] [Abstract][Full Text] [Related]
9. Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions.
Seden K; Back D
Curr Opin HIV AIDS; 2011 Nov; 6(6):514-26. PubMed ID: 22001895
[TBL] [Abstract][Full Text] [Related]
10. Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection.
Njoroge FG; Chen KX; Shih NY; Piwinski JJ
Acc Chem Res; 2008 Jan; 41(1):50-9. PubMed ID: 18193821
[TBL] [Abstract][Full Text] [Related]
11. Boceprevir, an NS3 protease inhibitor of HCV.
Berman K; Kwo PY
Clin Liver Dis; 2009 Aug; 13(3):429-39. PubMed ID: 19628159
[TBL] [Abstract][Full Text] [Related]
12. Prompt arrival of antivirals against hepatitis C for HIV patients.
Barreiro P; Vispo E
AIDS Rev; 2010; 12(4):242-3. PubMed ID: 21344779
[No Abstract] [Full Text] [Related]
13. New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals.
Seden K; Back D; Khoo S
J Antimicrob Chemother; 2010 Jun; 65(6):1079-85. PubMed ID: 20335191
[TBL] [Abstract][Full Text] [Related]
14. [Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C].
Sarrazin C; Berg T; Cornberg M; Dollinger M; Ferenci P; Hinrichsen H; Klinker H; Kraus M; Manns M; Mauss S; Peck-Radosavljevic M; Schmidt H; Spengler U; Wedemeyer H; Wirth S; Zeuzem S
Z Gastroenterol; 2012 Jan; 50(1):57-72. PubMed ID: 22222799
[TBL] [Abstract][Full Text] [Related]
15. Future hepatitis C virus treatment: interferon-sparing combinations.
Gane E
Liver Int; 2011 Jan; 31 Suppl 1():62-7. PubMed ID: 21205140
[TBL] [Abstract][Full Text] [Related]
16. Telaprevir: hope on the horizon, getting closer.
Weisberg IS; Jacobson IM
Clin Liver Dis; 2009 Aug; 13(3):441-52. PubMed ID: 19628160
[TBL] [Abstract][Full Text] [Related]
17. Trends in hepatitis C virus infection therapy: protease inhibitors a step forward in the era of direct acting antivirals.
Popescu C; Gliga S; Aramă V
Rom J Intern Med; 2012; 50(2):117-27. PubMed ID: 23326955
[TBL] [Abstract][Full Text] [Related]
18. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
Deming P; McNicholl IR
Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
[TBL] [Abstract][Full Text] [Related]
19. Telaprevir: a novel NS3/4 protease inhibitor for the treatment of hepatitis C.
Klibanov OM; Williams SH; Smith LS; Olin JL; Vickery SB
Pharmacotherapy; 2011 Oct; 31(10):951-74. PubMed ID: 21950642
[TBL] [Abstract][Full Text] [Related]
20. Advances in the treatment of hepatitis C.
Lawrence SP
Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
